In fact, a decrease in the bax/bcl-2 ratio is commonly observed in various tumors, and closely correlates with the inhibition of cell apoptosis, insusceptibility to undergo apoptosis, tumor recurrence and patients’ poor prognosis [20,21]. Here, BCL2 is linked to neoplasm.